Lysergic acid methyl ester

{{Chembox

| verifiedrevid = 421064697

| ImageFile = Lysergic acid methyl ester.svg

| ImageSize = 150px

| IUPACName = Methyl 6-methyl-9,10-didehydroergoline-8β-carboxylate

| SystematicName = Methyl (6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxylic acid

| OtherNames = Methyl lysergate

|Section1={{Chembox Identifiers

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}

| ChemSpiderID = 9589747

| InChI = 1/C17H18N2O2/c1-19-9-11(17(20)21-2)6-13-12-4-3-5-14-16(12)10(8-18-14)7-15(13)19/h3-6,8,11,15,18H,7,9H2,1-2H3/t11-,15-/m1/s1

| InChIKey = RNHDWLRHUJZABX-IAQYHMDHBA

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C17H18N2O2/c1-19-9-11(17(20)21-2)6-13-12-4-3-5-14-16(12)10(8-18-14)7-15(13)19/h3-6,8,11,15,18H,7,9H2,1-2H3/t11-,15-/m1/s1

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = RNHDWLRHUJZABX-IAQYHMDHSA-N

| CASNo_Ref = {{cascite|correct|??}}

| CASNo = 4579-64-0

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 13782F2619

| PubChem = 11414860

| SMILES = O=C(OC)[C@@H]3/C=C2/c4cccc1c4c(c[nH]1)C[C@H]2N(C3)C

}}

|Section2={{Chembox Properties

| C=17 | H=18 | N=2 | O=2

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Lysergic acid methyl ester is an analogue of lysergic acid.{{Citation |last=Hwang |first=Kristine Anne J. |title=Lysergic Acid Diethylamide (LSD) |date=2022 |url=http://www.ncbi.nlm.nih.gov/books/NBK482407/ |work=StatPearls |archive-url=https://web.archive.org/web/20221119181430/https://www.ncbi.nlm.nih.gov/books/NBK482407/ |place=Treasure Island (FL) |publisher=StatPearls Publishing |pmid=29494014 |access-date=2022-11-19 |archive-date=2022-11-19 |last2=Saadabadi |first2=Abdolreza}} It it has been reported to act on serotonin receptors.{{Cite journal |last=Libânio Osório Marta |first=Rui Filipe |date=2019-08-09 |title=Metabolism of lysergic acid diethylamide (LSD): an update |url=https://pubmed.ncbi.nlm.nih.gov/31266388/ |url-status=live |journal=Drug Metabolism Reviews |volume=51 |issue=3 |pages=378–387 |doi=10.1080/03602532.2019.1638931 |issn=1097-9883 |pmid=31266388 |archive-url=https://web.archive.org/web/20221119181244/https://pubmed.ncbi.nlm.nih.gov/31266388/ |archive-date=2022-11-19 |access-date=2022-11-19 |via=National Library of Medicine}}